PRKN and cancer: For example, metabolites associated with a PARK2 variant have recently been mapped which may inform the biological mechanisms underpinning associations between PARK2 and Parkinson’s disease, PTSD, diabetes mellitus, certain cancers, and inflammation ([41]; reviewed in [42]), see Figure 3.